Close Asset Management’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History

Close Asset Management’s Portfolio BMY.RT Stock Details BMY.RT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-200	Closed	–	–	236
2021 Q1	$0	Buy	+200	New	–	﹤0.01%	236

Other funds holding BMY.RT

JCI

Jet Capital Investors New York $51M AUM 48.01% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Close Asset Management's BMY.RT Position: Q2 2021 in Review

Close Asset Management sold out of Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) in Q2 2021, closing a stake of 200 shares.

Close Asset Management first reported a position in BMY.RT in Q1 2021 and held it in 1 quarter. The position peaked at $0 in Q1 2021. 8 funds tracked by Wall St. Rank hold BMY.RT as of Q2 2021.

Close Asset Management reported no remaining Bristol-Myers Squibb Company Contingent Value Rights position as of Q2 2021 after selling out during the quarter.
Close Asset Management sold 200 Bristol-Myers Squibb Company Contingent Value Rights shares in Q2 2021.
Close Asset Management first reported a position in Bristol-Myers Squibb Company Contingent Value Rights in Q1 2021 and held it in 1 quarter.
Close Asset Management's Bristol-Myers Squibb Company Contingent Value Rights position peaked at $0 in Q1 2021.
8 funds tracked by Wall St. Rank held Bristol-Myers Squibb Company Contingent Value Rights as of Q2 2021.

Based on Close Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.